Hemoglobin Adducts as a Marker of Exposure to Chemical Substances, Especially PRTR Class I Designated Chemical Substances
Open Access
- 1 September 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 48 (5) , 314-328
Abstract
Hemoglobin Adducts as a Marker of Exposure to Chemical Substances, Especially PRTR Class I Designated Chemical Substances: Masanori Ogawa, et al. Department of Environmental Health, University of Occupational and Environmental Health—Many new biomarkers are being studied, in addition to classical biomarkers, such as chemical substances and their metabolites in blood and urine and modified enzymes. Among these new biomarkers, hemoglobin adducts are thought to be especially useful for the estimation of chemical exposures. We review here the use of biomarkers for monitoring exposures to nine substances, mainly focusing on PRTR class I designated chemical substances, styrene, phenyloxirane (styrene oxide), 4,4’‐methylendiphenyl diisocyanate (MDI), 4,4’‐methylendianiline (MDA), 1,3‐butadiene, ethylene oxide, propylene oxide, acrylamide and acrylonitrile. Hemoglobin adduct levels were elevated after exposures to styrene, MDI, MDA, 1, 3‐butadiene, ethylene oxide, acrylamide and acrylonitrile. Moreover, hemoglobin adducts of butadiene, ethylene oxide, acrylamide and acrylonitrile have several useful advantages. For example, the hemoglobin adduct of 1,3‐butadiene is an even more useful biomarker of exposure than urinary metabolites, and in the case of ethylene oxide, even though the concentration of ethylene oxide‐Hb in the blood of workers did not exceed the value of the German exposure equivalent, a significant difference in it was found between workers and a control group. Also hemoglobin adducts of acrylamide and acrylonitrile can reflect their exposures because there are no urinary metabolites of acrylamide and acrylonitrile that are useful for exposure assessment. In addition to these advantages, hemoglobin adducts are superior to DNA adducts with respect to the availability of large amounts, availability of methods for chemical identification, and well‐defined life spans due to the absence of repair. Hemoglobin adducts can be effective biomarkers for assessing exposure to and the effects of chemicals.Keywords
This publication has 34 references indexed in Scilit:
- Styrene Oxide in Blood, Hemoglobin Adducts, and Urinary Metabolites in Human Volunteers Exposed to 13C8-Styrene VaporsToxicology and Applied Pharmacology, 2000
- Epoxybutene–Hemoglobin Adducts in Rats and Mice: Dose Response for Formation and Persistence During and Following Long-Term Low-Level Exposure to ButadieneToxicology and Applied Pharmacology, 1998
- Hemoglobin Adducts of Acrylamide and Acrylonitrile in Laboratory Workers, Smokers and NonsmokersChemical Research in Toxicology, 1997
- Monitoring of exposure to acrylonitrile by determination of N-(2-cyanoethyl)valine at the N-terminal position of haemoglobinCarcinogenesis, 1996
- Dosimetry of styrene 7,8-oxide in styrene- and styrene oxide-exposed mice and rats by quantification of haemoglobin adductsChemico-Biological Interactions, 1995
- Determination of Hemoglobin Adducts in Humans Occupationally Exposed to AcrylamideToxicology and Applied Pharmacology, 1993
- Application of Raney nickel to measure adducts of styrene oxide with hemoglobin and albuminChemical Research in Toxicology, 1993
- Monitoring of exposure to styrene oxide by GC-MS analysis of phenylhydroxyethyl esters in hemoglobinArchives of Toxicology, 1993
- Biologic markers in ethylene oxide-exposed workers and controlsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Analysis of styrene oxide–globin adducts based upon reaction with Raney nickelCarcinogenesis, 1990